Genetics, Neurology, Behavior, and Diet in Dementia
The Neuroscience of Dementia, Volume 2
Herausgeber: R Martin, Colin; Preedy, Victor R
Genetics, Neurology, Behavior, and Diet in Dementia
The Neuroscience of Dementia, Volume 2
Herausgeber: R Martin, Colin; Preedy, Victor R
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
"Diagnosis and Management in Dementia: The Neuroscience of Dementia, Volume 1 consolidates different fields of dementia into a single book, covering a range of subjects, including Alzheimer's disease, Lewy body dementia, mixed dementia, vascular dementia, physical activity, risk factors, mortality, biomarkers, SPECT, CT, MRI, questionnaires, nutrition, sleep, delirium, hearing loss, agitation, aggression, delusions, anxiety, depression, hallucinations, psychosis, senile plaques, tau and amyloid-beta, neuroinflammation, molecular biology, and more. With an impact on millions globally, and…mehr
- Genetics, Neurology, Behavior, and Diet in Parkinson's Disease209,99 €
- Harald SontheimerDiseases of the Nervous System168,99 €
- Zika Virus Impact, Diagnosis, Control, and Models258,99 €
- Handbook of Cognitive Behavioral Therapy by Disorder258,99 €
- Diagnosis and Treatment of Spinal Cord Injury260,99 €
- Cellular, Molecular, Physiological, and Behavioral Aspects of Spinal Cord Injury260,99 €
- Cellular, Molecular, Physiological, and Behavioral Aspects of Traumatic Brain Injury260,99 €
-
-
-
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
- Produktdetails
- Verlag: Elsevier Science
- Seitenzahl: 952
- Erscheinungstermin: 21. September 2020
- Englisch
- Gewicht: 2270g
- ISBN-13: 9780128158685
- ISBN-10: 0128158689
- Artikelnr.: 58817457
- Verlag: Elsevier Science
- Seitenzahl: 952
- Erscheinungstermin: 21. September 2020
- Englisch
- Gewicht: 2270g
- ISBN-13: 9780128158685
- ISBN-10: 0128158689
- Artikelnr.: 58817457
1. The neuron navigator 2 gene and Alzheimer's diseaseChun Xu, Brenda Bin
Su, Stephanie Lozano and Kesheng Wang
2. Interlinking polymorphisms, estrogens, and Alzheimer diseaseLu Hua Chen,
Leung Wing Chu and You-Qiang Song
3. Linking EEGs, Alzheimer disease, and the phosphatidylinositol-binding
clathrin assembly protein (PICALM) geneNatalya Ponomareva, Tatiana
Andreeva, Vitaly Fokin, Sergey Illarioshkin and Evgeny Rogaev
4. CD36 gene polymorphisms and Alzheimer's diseaseOmar erý, Nandu Goswami
and Vladimir J. Balcar
5. Genetic contributions to sporadic frontotemporal dementiaJessie S. Carr,
Daniel W. Sirkis and Jennifer S. Yokoyama
6. Clinical response to cholinesterase inhibitors in dementia: the role of
CYP2D6 and APOE genetic polymorphismsLuís Felipe José Ravic de Miranda,
Karina Braga Gomes and Paulo Caramelli
7. A1 and A2 purinergic receptor expression in dementiaJ. Mendiola-Precoma,
L.C. Berumen, A. Rodríguez-Cruz and G. García-Alcocer
8. Molecular aspects of metallothioneins in dementiasGemma Comes, Anna
Escrig, Yasmina Manso, Olaya Fernández-Gayol, Paula Sanchis, Amalia
Molinero, Mercedes Giralt, Javier Carrasco and Juan Hidalgo
9. Implication of microRNAs in Alzheimer's disease pathogenesisKatarzyn
Marta Zoltowska, Katarzyna Laskowska-Kaszub, Siranjeevi Nagaraj and
Urszula Wojda
10. Role of cellular oxidative stress in dementiaGiovanna Galliciotti,
Antonella De Jaco, Diego Sepulveda-Falla, Emanuela D'Acunto and Elena
Miranda
11. Toward an integrative understanding of the neuroinflammatory molecular
milieu in Alzheimer disease neurodegenerationJuan M. Zolezzi, Paulina
Villaseca and Nibaldo C. Inestrosa
12. Wnt signaling and dementiaCarolina Alquezár and Ángeles Martín-Requero
13. Linkage of atypical protein kinase C to Alzheimer diseaseRobert V.
Farese and Mini P. Sajan
14. Linking histone deacetylases and phosphodiesterase 5 in novel
treatments for Alzheimer's diseaseAna Garcia-Osta and Mar Cuadrado-Tejedor
15. Nuclear factor erythroid 2-related factor 2 in Alzheimer's
diseaseKelsey E. Murphy and Joshua J. Park
16. Implications of alpha- and beta-secretase expression and function in
Alzheimer's diseaseSven Reinhardt and Kristina Endres
17. Methylation analysis of DNA in Alzheimer's diseaseFabio Coppedè
18. The signalosome malfunctions in age-associated neuropathologiesRicardo
Puertas-Avendaño, David Quinto-Alemany, Miriam González-Gómez and Raquel
Marin
19. FAM3C in Alzheimer's disease: a risk-related molecule and potential
therapeutic targetMasaki Nishimura, Naoki Watanabe, Emi Hibino, Masaki
Nakano, Yachiyo Mitsuishi, Lei Liu and Takuma Sugi
20. Amylin and amylin receptors in Alzheimer's diseaseWen Fu and Jack H.
Jhamandas
21. Mammalian target of rapamycin complexes: regulation and Alzheimer's
diseaseHenry Querfurth and Han-Kyu Lee
22. Mammalian target of rapamycin complexes: protein synthesis and
autophagy, Parkinson's disease, amyotrophic lateral sclerosis, and
frontotemporal dementiaHenry Querfurth and Han-Kyu Lee
23. Linking CD200 in brains and dementia: molecular aspects of
neuroinflammationDouglas Gordon Walker
Part II: Neurological, physiological and imaging
24. Hippocampal atrophy associated with dementia risk factors and
dementiaHiroshi Yao, Yuko Araki, Fumio Yamashita, Makoto Sasaki and Manabu
Hashimoto
25. Inflammation and insulin resistance in Alzheimer's disease: partners in
crimeYuval Nash and Dan Frenke
26. Brain susceptibility to hypoxia/hypoxemia and metabolic dysfunction in
Alzheimer's disease: insights from animal and in vitro modelsVito Antonio
Baldassarro, Andrea Bighinati, Michele Sannia, Luciana Giardino and Laura
Calzà
27. Neuropeptides and neurolipids: what they are and how they relate to
Alzheimer's diseaseIván Manuel, Laura Lombardero, Alberto Llorente-Ovejero
and Rafael Rodríguez-Puertas
28. Neurotransmitter receptors in Alzheimer's disease: from glutamatergic
to cholinergic receptorsLaura Lombardero, Alberto Llorente-Ovejero, Iván
Manuel and Rafael Rodríguez-Puertas
29. Aß42-a7-like nicotinic acetylcholine receptors and Alzheimer's
diseaseHoau-Yan Wang and Amber Khan
30. Synaptosomal bioenergetic defects in Alzheimer's diseasePamela V.
Martino Adami and Laura Morelli
31. Limitations of amyloid imaging in Alzheimer's diseaseDavid Weidman
32. Linking gradient echo plural contrast imaging metrics of tissue
microstructure with Alzheimer diseaseDmitriy A. Yablonskiy, Tammie L.
Benzinger and John C. Morris
33. Hypertensive disorders during pregnancy and later dementia: is there a
connection?Ellika Andolf
34. Unraveling the contributions of sleep dysfunction to Alzheimer's
diseaseElie Gottlieb, Natalie A. Grima, Mark Howard, Amy Brodtmann and
Matthew P. Pase
Part III: Behaviour and psychopathology
35. Overview of behaviors in dementiaDorothy M. Grillo and Rachel Anderson
36. Delirium superimposed on dementia: a clinical challenge from diagnosis
to treatmentMorandi Alessandro, Pozzi Christian, Grossi Eleonora and
Bellelli Giuseppe
37. Self-consciousness deficits in dementiaEva M. Arroyo-Anlló and Roger
Gil
38. Attentional impairments to novel images in dementiaCelina S. Liu,
Michael Rosen, Nathan Herrmann and Krista L. Lanctôt
39. Frontal lobe syndrome and dementiasPetronilla Battista, Chiara Griseta,
Rosa Capozzo, Madia Lozupone, Rodolfo Sardone, Francesco Panza and
Giancarlo Logroscino
40. The stigma of dementiaAlbert Aboseif and Benjamin K.P. Woo
41. Delusions in dementiasMadia Lozupone, Maddalena La Montagna, Antonello
Bellomo, Petronilla Battista, Davide Seripa, Antonio Daniele, Antonio
Greco, Onofrio Resta, Giancarlo Logroscino and Francesco Panza
42. Linking motor speech function and dementiaMatthew L. Poole and Adam P.
Vogel
43. Spatial navigation and Alzheimer's diseaseLaura E. Berkowitz, Ryan E.
Harvey and Benjamin J. Clark
44. Violence and dementiaG. Cipriani, S. Danti, A. Nuti, L. Picchi and M.
Di Fiorino
45. Factors contributing to protection and vulnerability in dementia
caregiversFan Zhang, Sheung-Tak Cheng and Manuel Gonçalves-Pereira
Part IV: Diet, nutrition and environment
46. Nutritional status of dementia and management using dietary taurine
supplementationMi Ae Bae and Kyung Ja Chang
47. Selenium and Alzheimer's diseaseAdriana Gisele Hertzog da Silva Leme
and Barbara R. Cardoso
48. Linking adiponectin and obesity in dementiaMa1gorzata Bednarska-Makaruk
49. The impact of the gut microbiome in Alzheimer's disease: cause or
consequence?Malena dos Santos Guilherme and Kristina Endres
50. (-)-Epigallocatechin-3-gallate and Alzheimer's diseaseLaura Xicota and
Rafael de la Torre
51. Lead, cadmium and Alzheimer's diseaseKelly M. Bakulski, Howard Hu and
Sung Kyun Park
Part V: Models and modelling in dementia
52. Alzheimer model 5xfad mice and applications to dementia: transgenic
mouse models, a focus on neuroinflammation, microglia, and food-derived
componentsTatsuhiro Ayabe and Yasuhisa Ano
53. Use of 192 IgG-saporin as a model of dementia and its applicationJ.W.
Chang and Y.S. Park
54. Amyloid beta 1e42-induced animal model of dementia: a reviewJosiane
Budni and Jade de Oliveira
55. Resources for the neuroscience of dementiaRajkumar Rajendram and
Victor R. Preedy
1. The neuron navigator 2 gene and Alzheimer's diseaseChun Xu, Brenda Bin
Su, Stephanie Lozano and Kesheng Wang
2. Interlinking polymorphisms, estrogens, and Alzheimer diseaseLu Hua Chen,
Leung Wing Chu and You-Qiang Song
3. Linking EEGs, Alzheimer disease, and the phosphatidylinositol-binding
clathrin assembly protein (PICALM) geneNatalya Ponomareva, Tatiana
Andreeva, Vitaly Fokin, Sergey Illarioshkin and Evgeny Rogaev
4. CD36 gene polymorphisms and Alzheimer's diseaseOmar erý, Nandu Goswami
and Vladimir J. Balcar
5. Genetic contributions to sporadic frontotemporal dementiaJessie S. Carr,
Daniel W. Sirkis and Jennifer S. Yokoyama
6. Clinical response to cholinesterase inhibitors in dementia: the role of
CYP2D6 and APOE genetic polymorphismsLuís Felipe José Ravic de Miranda,
Karina Braga Gomes and Paulo Caramelli
7. A1 and A2 purinergic receptor expression in dementiaJ. Mendiola-Precoma,
L.C. Berumen, A. Rodríguez-Cruz and G. García-Alcocer
8. Molecular aspects of metallothioneins in dementiasGemma Comes, Anna
Escrig, Yasmina Manso, Olaya Fernández-Gayol, Paula Sanchis, Amalia
Molinero, Mercedes Giralt, Javier Carrasco and Juan Hidalgo
9. Implication of microRNAs in Alzheimer's disease pathogenesisKatarzyn
Marta Zoltowska, Katarzyna Laskowska-Kaszub, Siranjeevi Nagaraj and
Urszula Wojda
10. Role of cellular oxidative stress in dementiaGiovanna Galliciotti,
Antonella De Jaco, Diego Sepulveda-Falla, Emanuela D'Acunto and Elena
Miranda
11. Toward an integrative understanding of the neuroinflammatory molecular
milieu in Alzheimer disease neurodegenerationJuan M. Zolezzi, Paulina
Villaseca and Nibaldo C. Inestrosa
12. Wnt signaling and dementiaCarolina Alquezár and Ángeles Martín-Requero
13. Linkage of atypical protein kinase C to Alzheimer diseaseRobert V.
Farese and Mini P. Sajan
14. Linking histone deacetylases and phosphodiesterase 5 in novel
treatments for Alzheimer's diseaseAna Garcia-Osta and Mar Cuadrado-Tejedor
15. Nuclear factor erythroid 2-related factor 2 in Alzheimer's
diseaseKelsey E. Murphy and Joshua J. Park
16. Implications of alpha- and beta-secretase expression and function in
Alzheimer's diseaseSven Reinhardt and Kristina Endres
17. Methylation analysis of DNA in Alzheimer's diseaseFabio Coppedè
18. The signalosome malfunctions in age-associated neuropathologiesRicardo
Puertas-Avendaño, David Quinto-Alemany, Miriam González-Gómez and Raquel
Marin
19. FAM3C in Alzheimer's disease: a risk-related molecule and potential
therapeutic targetMasaki Nishimura, Naoki Watanabe, Emi Hibino, Masaki
Nakano, Yachiyo Mitsuishi, Lei Liu and Takuma Sugi
20. Amylin and amylin receptors in Alzheimer's diseaseWen Fu and Jack H.
Jhamandas
21. Mammalian target of rapamycin complexes: regulation and Alzheimer's
diseaseHenry Querfurth and Han-Kyu Lee
22. Mammalian target of rapamycin complexes: protein synthesis and
autophagy, Parkinson's disease, amyotrophic lateral sclerosis, and
frontotemporal dementiaHenry Querfurth and Han-Kyu Lee
23. Linking CD200 in brains and dementia: molecular aspects of
neuroinflammationDouglas Gordon Walker
Part II: Neurological, physiological and imaging
24. Hippocampal atrophy associated with dementia risk factors and
dementiaHiroshi Yao, Yuko Araki, Fumio Yamashita, Makoto Sasaki and Manabu
Hashimoto
25. Inflammation and insulin resistance in Alzheimer's disease: partners in
crimeYuval Nash and Dan Frenke
26. Brain susceptibility to hypoxia/hypoxemia and metabolic dysfunction in
Alzheimer's disease: insights from animal and in vitro modelsVito Antonio
Baldassarro, Andrea Bighinati, Michele Sannia, Luciana Giardino and Laura
Calzà
27. Neuropeptides and neurolipids: what they are and how they relate to
Alzheimer's diseaseIván Manuel, Laura Lombardero, Alberto Llorente-Ovejero
and Rafael Rodríguez-Puertas
28. Neurotransmitter receptors in Alzheimer's disease: from glutamatergic
to cholinergic receptorsLaura Lombardero, Alberto Llorente-Ovejero, Iván
Manuel and Rafael Rodríguez-Puertas
29. Aß42-a7-like nicotinic acetylcholine receptors and Alzheimer's
diseaseHoau-Yan Wang and Amber Khan
30. Synaptosomal bioenergetic defects in Alzheimer's diseasePamela V.
Martino Adami and Laura Morelli
31. Limitations of amyloid imaging in Alzheimer's diseaseDavid Weidman
32. Linking gradient echo plural contrast imaging metrics of tissue
microstructure with Alzheimer diseaseDmitriy A. Yablonskiy, Tammie L.
Benzinger and John C. Morris
33. Hypertensive disorders during pregnancy and later dementia: is there a
connection?Ellika Andolf
34. Unraveling the contributions of sleep dysfunction to Alzheimer's
diseaseElie Gottlieb, Natalie A. Grima, Mark Howard, Amy Brodtmann and
Matthew P. Pase
Part III: Behaviour and psychopathology
35. Overview of behaviors in dementiaDorothy M. Grillo and Rachel Anderson
36. Delirium superimposed on dementia: a clinical challenge from diagnosis
to treatmentMorandi Alessandro, Pozzi Christian, Grossi Eleonora and
Bellelli Giuseppe
37. Self-consciousness deficits in dementiaEva M. Arroyo-Anlló and Roger
Gil
38. Attentional impairments to novel images in dementiaCelina S. Liu,
Michael Rosen, Nathan Herrmann and Krista L. Lanctôt
39. Frontal lobe syndrome and dementiasPetronilla Battista, Chiara Griseta,
Rosa Capozzo, Madia Lozupone, Rodolfo Sardone, Francesco Panza and
Giancarlo Logroscino
40. The stigma of dementiaAlbert Aboseif and Benjamin K.P. Woo
41. Delusions in dementiasMadia Lozupone, Maddalena La Montagna, Antonello
Bellomo, Petronilla Battista, Davide Seripa, Antonio Daniele, Antonio
Greco, Onofrio Resta, Giancarlo Logroscino and Francesco Panza
42. Linking motor speech function and dementiaMatthew L. Poole and Adam P.
Vogel
43. Spatial navigation and Alzheimer's diseaseLaura E. Berkowitz, Ryan E.
Harvey and Benjamin J. Clark
44. Violence and dementiaG. Cipriani, S. Danti, A. Nuti, L. Picchi and M.
Di Fiorino
45. Factors contributing to protection and vulnerability in dementia
caregiversFan Zhang, Sheung-Tak Cheng and Manuel Gonçalves-Pereira
Part IV: Diet, nutrition and environment
46. Nutritional status of dementia and management using dietary taurine
supplementationMi Ae Bae and Kyung Ja Chang
47. Selenium and Alzheimer's diseaseAdriana Gisele Hertzog da Silva Leme
and Barbara R. Cardoso
48. Linking adiponectin and obesity in dementiaMa1gorzata Bednarska-Makaruk
49. The impact of the gut microbiome in Alzheimer's disease: cause or
consequence?Malena dos Santos Guilherme and Kristina Endres
50. (-)-Epigallocatechin-3-gallate and Alzheimer's diseaseLaura Xicota and
Rafael de la Torre
51. Lead, cadmium and Alzheimer's diseaseKelly M. Bakulski, Howard Hu and
Sung Kyun Park
Part V: Models and modelling in dementia
52. Alzheimer model 5xfad mice and applications to dementia: transgenic
mouse models, a focus on neuroinflammation, microglia, and food-derived
componentsTatsuhiro Ayabe and Yasuhisa Ano
53. Use of 192 IgG-saporin as a model of dementia and its applicationJ.W.
Chang and Y.S. Park
54. Amyloid beta 1e42-induced animal model of dementia: a reviewJosiane
Budni and Jade de Oliveira
55. Resources for the neuroscience of dementiaRajkumar Rajendram and
Victor R. Preedy